排序方式: 共有77条查询结果,搜索用时 0 毫秒
71.
The complexity and advanced nature of modern biotechnology, and its extensive implications for society regarding prosperity, risk and ethics, make a view of the future that is comprehensible and transparent to society desirable. The objective of this feasibility study was to investigate methodologies for strategic planning and regulatory decision-making in technologies involving genetically modified (GM) crops. The planning and regulatory decisions of both the biotechnology industry and public authorities are considered. In the study, knowledge and opinion about a well-defined problem complex are systematically brought together in the consultation of a larger number of stakeholders and experts representing as many major perspectives as possible. On the basis of a test case on the development of a GM-ryegrass, this paper suggests a methodological approach to the uncertainties faced by the biotech industry and public authorities when GM crops are commercialized. The method used was a technology foresight (TF) framework, using a life cycle inventory (LCI) to define the problem complex, a stakeholder panel to identify drivers (of change) that influence the direction of future developments, and weighted stakeholder questionnaires to prioritize these drivers. Once quantified, the weighted stakeholder opinion generated a clear criterion for prioritizing drivers that were judged to be important in the future development of a GM-ryegrass but whose precise impact was uncertain. The four drivers prioritized were: being the first to market the GM-ryegrass, an efficient network on biomolecular know-how, public dialogue and participation in regulation procedures and utility value. 相似文献
72.
In exploration networks the key-organisational question is not how to organise a division of labour but instead how to create novelty. The aim of this paper is to develop an understanding of how such novelty in exploration networks is created. Based on an empirical analysis of the multimedia and biotechnology industries in the Netherlands, this paper shows that exploration networks face a trade-off between diversity and selection. Moreover, the findings indicate that depending on the type of exploration task, exploration networks need to make a combination of density and tie strength in such a way that diversity and selection are aligned. The paper concludes, among others, that the views of Burt, Coleman and Granovetter should not be seen as contradictory, but rather as proponents of complementary views. 相似文献
73.
This paper sheds light on the questions, Why does knowledge spill over? and How does knowledge spill over? The answer to these questions we suggest lies in the incentives confronting scientists to appropriate the expected value of their knowledge considered in the context of their path-dependent career trajectories. In particular, we focus on the ability of scientists to appropriate the value of knowledge embedded in their human capital along with the incentive structure influencing if and how scientists choose to commercialize their knowledge. We conclude that the spillover of knowledge from the source creating it, such as a university, research institute, or industrial corporation, to a new-firm startup facilitates the appropriation of knowledge for the individual scientist(s) but not necessarily for the organization creating that new knowledge in the first place. 相似文献
74.
Margaret L. Eaton 《Journal of Business Ethics》2008,77(1):99-109
This paper discusses the criticisms that exist about corporate use of ethics advice by bioscience companies and offers suggestions on how ethics advisors can be used so as to maximize their utility and avoid the criticism. 相似文献
75.
我国生物技术发展态势分析 总被引:2,自引:0,他引:2
统计分析了我国2000—2005年生物技术领域发表的论文情况,揭示我国生物技术领域的发展趋势。 相似文献
76.
随着市场经济的不断发展,我国科学技术取得了较大的突破。尤其是生物技术在食品加工及食物成分检测过程中发挥了重要作用。自从三聚氰胺食品事件出现之后,我国食品加工行业加强了市场监管,特别是在乳制品加工生产中,采用更加先进的生物技术,对乳制品中的相关有害成分和不达标成分进行检测分析,以此确保了我国食品生产加工的卫生与安全。基于此,从我国食品加工生产行业中乳制品加工生产实际出发,通过对生物技术在乳制品加工中的具体应用情况进行分析,以此确保我国乳制品生产企业能够健康、稳定发展。 相似文献
77.
Companies in the biotechnology industry face major challenges in developing and commercializing new products. Focusing on publicly traded biotechnology firms that are not members of university incubators or research parks, this paper argues that the links these companies develop with universities can have beneficial effects on a company's operations. Analysis of 2457 alliances undertaken by 147 biotechnology firms shows that companies with university linkages have lower research and development (R&D) expenses while having higher levels of innovative output. However, the results do not support the proposition that companies with university linkages achieve higher financial performance than similar firms without such linkages. 相似文献